Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: A GELA study

This publication has 10 references indexed in Scilit:

• Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
  Journal of Clinical Oncology, 1998
• Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.
  Journal of Clinical Oncology, 1998
• Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
  Journal of Clinical Oncology, 1998
• Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients
  Annals of Oncology, 1997
• Treatment of follicular follicle centre lymphomas: current status and future perspectives
  Journal of Internal Medicine, 1997
• A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma
  Blood, 1997
• Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma
  New England Journal of Medicine, 1993
• A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• A randomized comparison of two doses of human lymphoblastoid interferon- alpha in hairy cell leukemia. Wellcome HCL Study Group
  Blood, 1991
• A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
  Journal of Clinical Oncology, 1989